To include your compound in the COVID-19 Resource Center, submit it here.

Asterias raises $10.4M in registered direct offering

On Oct. 19, Asterias Biotherapeutics Inc. (NYSE-M:AST)

Read the full 73 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE